Figure 13 — A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients

Research Paper|Volume 15, Issue 18|pp. 9633–9660

A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients

Back to articleFigure 13(13 of 13)

100%

Figure 13.Risk model related to the immune cell markers in LUAD. (A) CSF1R; (B) STAT5A; (C) STAT5B; (D) ITGAM; (E) BCL6; (F) CD274; (G) ITGAX; (H) CD8B; (I) HLA-DPB1; (J) CD8A; (K) TGFB1; (L) HLA-DPA1; (M) IL21; (N) HLA-DQB1; (O) S4A4A; (P) CCR7; (Q) CD1C; (R) STAT3; (S) NRP1; (T)GZMB. Abbreviation: LUAD: lung adenocarcinoma.